Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 393-399 , August 2010

New developments in arc radiation therapy: A review

  • David A. Palma

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Tel.: +31 20 44 40648; fax: +31 20 44 40410.
    • ,
  • Wilko F.A.R. Verbakel

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Karl Otto

      Affiliations

    • University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Suresh Senan

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands

Received 12 November 2009 ,Revised 14 January 2010 ,Accepted 24 January 2010.

References 

  1. Robertson JM, Kessler ML, Lawrence TS. Clinical results of three-dimensional conformal irradiation. J Natl Cancer Inst. 1994;86:968–974
  2. Galvin JM, DeNeve W. Intensity modulating and other radiation therapy devices for dose painting. J Clin Oncol. 2007;25:924–930
  3. Wang X, Zhang X, Dong L, Liu H, Wu Q, Mohan R. Development of methods for beam angle optimization for IMRT using an accelerated exhaustive search strategy. Int J Radiat Oncol Biol Phys. 2004;60:1325–1337
  4. Verellen D, Ridder MD, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer. 2007;7:949–960
  5. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys. 2001;51:880–914
  6. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1–7
  7. Wang JZ, Li XA, D’Souza WD, Stewart RD. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys. 2003;57:543–552
  8. Lagerwaard FJ, Haasbeek CJA, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage i non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685–692
  9. Mackie TR, Holmes T, Swerdloff S, Reckwerdt P, Deasy JO, Yang J, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys. 1993;20:1709–1719
  10. Fenwick JD, Tome WA, Soisson ET, Mehta MP, Rock MT. Tomotherapy and other innovative IMRT delivery systems. Semin Radiat Oncol. 2006;16:199–208
  11. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35:310–317
  12. Wang C, Luan S, Tang G, Chen DZ, Earl MA, Yu CX. Arc-modulated radiation therapy (AMRT): a single-arc form of intensity-modulated arc therapy. Phys Med Biol. 2008;53:6291–6303
  13. Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. Phys Med Biol. 1995;40:1435–1449
  14. Guckenberger M, Richter A, Krieger T, Wilbert J, Baier K, Flentje M. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?. Radiotherapy Oncol. 2009;93:259–265
  15. Beavis AW. Is tomotherapy the future of IMRT?. Br J Radiol. 2004;77:285–295
  16. Low DA, Mutic S, Dempsey JF, Markman J, Goddu SM, Purdy JA. Abutment region dosimetry for serial tomotherapy. Int J Radiat Oncol Biol Phys. 1999;45:193–203
  17. Mackie TR. History of tomotherapy. Phys Med Biol. 2006;51:R427–R453
  18. Bijdekerke P, Verellen D, Tournel K, Vinh-Hung V, Somers F, Bieseman P, et al. TomoTherapy: implications on daily workload and scheduling patients. Radiother Oncol. 2008;86:224–230
  19. Beldjoudi G, Yartsev S, Bauman G, Battista J, Van DJ. Schedule for CT image guidance in treating prostate cancer with helical tomotherapy. Br J Radiol 2009 [Epub ahead of print].
  20. Bichay T, Cao D, Orton CG. Point/counterpoint helical tomotherapy will ultimately replace linear accelerator based IMRT as the best way to deliver conformal radiotherapy. Med Phys. 2008;35:1625–1628
  21. Bauman G, Yartsev S, Rodrigues G, Lewis C, Venkatesan VM, Yu E, et al. A prospective evaluation of helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;68:632–641
  22. Kron T, Grigorov G, Yu E, Yartsev S, Chen JZ, Wong E, et al. Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy. Phys Med Biol. 2004;49:3675–3690
  23. Yartsev S, Kron T, Cozzi L, Fogliata A, Bauman G. Tomotherapy planning of small brain tumours. Radiother Oncol. 2005;74:49–52
  24. Lee TF, Fang FM, Chao PJ, Su TJ, Wang LK, Leung SW. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol. 2008;89:89–96
  25. Aoyama H, Westerly DC, Mackie TR, Olivera GH, Bentzen SM, Patel RR, et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys. 2006;64:962–967
  26. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:996–1001
  27. Clivio A, Fogliata A, Franzetti-Pellanda A, Nicolini G, Vanetti E, Wyttenbach R, et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: a treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009;92:118–124
  28. Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008;89:180–191
  29. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R et al. Volumetric modulated arc therapy (VMAT) for delivery of prostate radiotherapy: reduction in treatment time and monitor unit requirements compared to intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys;72(1):S312.9-1-0008 [Ref Type: Abstract].
  30. Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V et al. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys 2009 [Epub ahead of print].
  31. Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys. 2009;74:252–259
  32. Vanetti E, Clivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal JP, et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009;92:111–117
  33. Verbakel WF, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol. 2009;93:122–124
  34. Bedford JL, Warrington AP. Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys. 2009;73:537–545
  35. Fogliata A, Clivio A, Nicolini G, Vanetti E, Cozzi L. Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother Oncol. 2008;89:254–262
  36. Fogliata A, Yartsev S, Nicolini G, Clivio A, Vanetti E, Wyttenbach R, et al. On the performances of intensity modulated protons, RapidArc and helical tomotherapy for selected paediatric cases. Radiat Oncol. 2009;4:2
  37. Mohan R. Dueling technologies: in regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72:575–581). Int J Radiat Oncol Biol Phys. 2009;75:6–7
  38. Murthy V, Gupta T, Kadam A, Ghosh-Laskar S, Budrukkar A, Phurailatpam R, et al. Time trial: a prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers. J Cancer Res Ther. 2009;5:107–112
  39. Miles EA, Clark CH, Urbano MTG, Bidmead M, Dearnaley DP, Harrington KJ, et al. The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiotherapy Oncol. 2005;77:241–246
  40. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329–337
  41. Hoogeman MS, Nuyttens JJ, Levendag PC, Heijmen BJM. Time dependence of intrafraction patient motion assessed by repeat stereoscopic imaging. Int J Radiat Oncol Biol Phys. 2008;70:609–618
  42. Yang W, Van AR, Read P, Larner J, Benedict S, Sheng K. The implication of non-cyclic intrafractional longitudinal motion in SBRT by tomotherapy. Phys Med Biol. 2009;54:2875–2884
  43. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004;59:242–249
  44. Bewes JM, Suchowerska N, Jackson M, Zhang M, McKenzie DR. The radiobiological effect of intra-fraction dose-rate modulation in intensity modulated radiation therapy (IMRT). Phys Med Biol. 2008;53:3567–3578
  45. Moiseenko V, Duzenli C, Durand RE. In vitro study of cell survival following dynamic MLC intensity-modulated radiation therapy dose delivery. Med Phys. 2007;34:1514–1520
  46. Sterzing F, Munter MW, Schafer M, Haering P, Rhein B, Thilmann C, et al. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy. Strahlenther Onkol. 2005;181:42–48
  47. Wu QJ, Yoo S, Kirkpatrick JP, Thongphiew D, Yin FF. Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. Int J Radiat Oncol Biol Phys. 2009;75:1596–1604
  48. Ling CC, Archambault Y, Bocanek J, Ling CC, Zhang P, LoSasso T, et al. Scylla and Charybdis: longer beam-on time or lesser conformality–the dilemma of tomotherapy. Int J Radiat Oncol Biol Phys. 2009;75:8–9
  49. Mehta M, Hoban P, Mackie TR. Commissioning and quality assurance of RapidArc radiotherapy delivery system: In Regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72;575–581): absence of data does not constitute proof; The proof is in tasting the pudding. Int J Radiat Oncol Biol Phys. 2009;75:4–6
  50. Ling CC, Zhang P, Archambault Y, Bocanek J, Tang G, LoSasso T. Commissioning and quality assurance of RapidArc radiotherapy delivery system. Int J Radiat Oncol Biol Phys. 2008;72:575–581
  51. Reynders T, Tournel K, De Coninck P, Heymann S, Vinh-Hung V, Van Parijs H, et al. Dosimetric assessment of static and helical tomotherapy in the clinical implementation of breast cancer treatments. Radiotherapy Oncol. 2009;93:71–79
  52. Kamino Y, Takayama K, Kokubo M, Narita Y, Hirai E, Kawawda N, et al. Development of a four-dimensional image-guided radiotherapy system with a gimbaled X-ray head. Int J Radiat Oncol Biol Phys. 2006;66:271–278
  53. Mackonis EC, Suchowerska N, Zhang M, Ebert M, McKenzie DR, Jackson M. Cellular response to modulated radiation fields. Phys Med Biol. 2007;52:5469–5482
  54. Yang W, Wang L, Larner J, Read P, Benedict S, Sheng K. Tumor cell survival dependence on helical tomotherapy, continuous arc and segmented dose delivery. Phys Med Biol. 2009;54:6635–6643
  55. Bentzen SM. Randomized controlled trials in health technology assessment: overkill or overdue?. Radiother Oncol. 2008;86:142–147
  56. Hurkmans C, Cuijpers J, Lagerwaard F, Widder J, van der Heide U, Schuring D, et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol. 2009;4:1
  57. Sterzing F, Schubert K, Sroka-Perez G, Kalz J, Debus J, Herfarth K. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol. 2008;184:8–14
  58. Cozzarini C, Fiorino C, Di Muzio N, Alongi F, Broggi S, Cattaneo M, et al. Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiotherapy Oncol. 2007;84:164–170
  59. Shaffer R, Morris WJ, Moiseenko V, Welsh M, Crumley C, Nakano S, et al. Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study. Clin Oncol (R Coll Radiol). 2009;21:401–407
  60. Hodge W, Tom WA, Jaradat HA, Orton NP, Khuntia D, Traynor A, et al. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Acta Oncol. 2006;45:890–896
  61. Lagerwaard FJ, Meijer OWM, van der Hoorn EAP, Verbakel WFAR, Slotman BJ, Senan S. Volumetric modulated arc radiotherapy for vestibular Schwannomas. Int J Radiat Oncol Biol Phys. 2009;74:610–615
  62. Fuss M, Shi C, Papanikolaou N. Tomotherapeutic stereotactic body radiation therapy: Techniques and comparison between modalities. Acta Oncol. 2006;45:953–960

PII: S0305-7372(10)00019-8

doi: 10.1016/j.ctrv.2010.01.004

Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 393-399 , August 2010

Article Tools

* Image Usage & Resolution